chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had previously identified 3-beat runs of vtach 12/3/20 and was on 30d heart monitor during Dec 2020. On day 5 after dose 1 of vaccine, I  had a 13-beat run of vtach and was advised to go to ER to be admitted; I do not know whether this episode was related to vaccine, but as I understand, it was the only longer run (13 beat run) of vtach that was reported on the data from 30d cardiac monitor analysis. I was in hospital from 12/27-12/31/20 for cardiac eval. I was advised by pharmacist to report this to vaers.
horrible sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (horrible sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M204) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (horrible sore arm). At the time of the report, PAIN IN EXTREMITY (horrible sore arm) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-058336 (Patient Link).
Telephone call received from agent to field supervisor stating she received flu shot on 12/26/00 and had a seizure on 12/30/00. History of meningioma surgery removed but off since then. Seizure meds. Called PP who stated no correlation to flu shot but restarted her on seizure meds. (Tegretol). No further seizures since that date.
This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER2613), at the age of 61, via an unspecified route of administration, left arm, Mar 31, 2021, at 08:00, single dose, for COVID-19 immunisation. Medical history included post-menopausal. Concomitant medications included estradiol, hydrochlorothiazide and vitamins, all from unknown date for unknown indication. The patient previously took morphine and experienced drug allergy. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 31, 2021, at 17:00, patient experienced migraine (the night post-injection), lingering headaches, sporadic dizziness and easily fatigued. No therapeutic measures taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The outcome of migraine (the night post-injection), lingering headaches, sporadic dizziness and easily fatigued: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.
On 5/19 fever had fever of 102.5degrees, parents gave pt juice and fever started to decrease. Pt woke up at night and was given children's tylenol by parent, parent reports other behavior besides fever was normal. On 5/20 parent contacted doctor who recommended medicine with ibuprofen. Pharmacist gave parent motrin.
Increase ringing in right ear.    Ringing started in left ear.    Headaches & Dizziness. Cold like symptoms--some coughing, sneezing, runny nose. Shortness of breath.
Approximately 15-20 minutes after administration of vaccine, patient reported onset of itching bilateral upper arms/shoulders and upper thighs. No rash or hives seen. Described throat as "feeling funny" but could not be more specific. No difficulty swallowing, no shortness of breath, and no chest symptoms. No other concerns reported.  Patient given oral bendaryl 25mg at 3:25pm. Reported gradual improvement with Benadryl with complete resolvement of symptoms by 4:20pm. Observation for additional 30-40 minutes without return of symptoms.  Serial exams and VSs obtained, stable exam without any signs of respiratory distress.  No lip, facial, or throat swelling observed. Lungs CTA without wheezes. VSs remained stable.  Patient returned to clinic next AM for recheck and reported doing well without return of previous symptoms in the interim.
Information has been received from a mother regarding her 20 year old daughter who in August 2007, was vaccinated with the first dose of Gardasil (lot# unspecified).  The patient was given a second dose of the vaccination sometime in October 2007.  Concomitant therapy included corticosteroids (unspecified).  It was reported that after receiving the second dose, "during the 1st week of November" the patient experienced severe myalgia of her joints and swelling in her hands.  The mother reported that all tests that were done to diagnose arthritis came back negative (Anti CCP, Rheumatoid arthritis testing).  The patient did not have this reaction after the 1st dose in August.  The patient's myalgia of the joints and swelling in hands persisted.  The patient's outcome was reported as not recovered.  Additional information has been requested. Follow-up received 04/16/2008 from the physician who reported that the patient was diagnosed with arthritis. Additional information has been requested.
08/28/1998. the vaccinee received her first left deltoid dose of Hepatitis B vax. Twenty-four hours later she became psychotic and was hospitalized. She was treated with Zyprexa for 2 months and recovered. The most recent information received on 05/11 reports the vaccinee well since the event.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 24-FEB-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 32 degrees Fahrenheit (0 degrees Celsius) (lowest recorded temperature) for 296 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Wife states patient started experiencing a red rash on arm that fades to pink 1 week after shot administered. Wife states that rash burns and is itchy to patient. Wife states she went online and found what she believes is called "Covid arm." Wife states they have been doing benadyrl and cold rag on arm to help with symptoms.
Resident was noted unresponsive, no respiration, no blood pressure, no pulse, code blue called according to facility protocol, resident is full code, CPR started, 911 called, arrived and took  over from staff. Resident was pronounced dead at 1:16pm 1/18/21
After receiving Fluvirin injection left, then returned 10 min. later complaining of difficulty swallowing, arm discomfort, diff - given Epinephrine 0.5 cc. Taken to hospital by daughter.
I got a rash on my neck & back The rash was red, & had red bumps; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (I got a rash on my neck & back The rash was red, & had red bumps) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (PCN), Allergy to antibiotic (Tetracycline), Drug allergy (Sulfa), Drug allergy (Codeine), Drug allergy (Celecoxib) and Latex allergy.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced RASH ERYTHEMATOUS (I got a rash on my neck & back The rash was red, & had red bumps). At the time of the report, RASH ERYTHEMATOUS (I got a rash on my neck & back The rash was red, & had red bumps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient stated that rash is getting a little better. But she keep having flare ups. No relevant concomitant product were reported No treatment medication was provided   This case was linked to MOD-2021-385964 (Patient Link).
Pain in right ear; Swollen gums in lower right quadrant of mouth; Extreme pain in jaw; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 01Apr2021 at 09:45 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not included. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 08:00, the patient experienced pain in right ear, swollen gums in lower right quadrant of mouth and extreme pain in jaw (ruled out as dental issue). The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with antibiotics prophylactically. The clinical outcome of pain in right ear, swollen gums in lower right quadrant of mouth and extreme pain in jaw was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age and gender. No information about the patients' medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On unknown dates, it could not be could out that the patients were vaccinated with improperly stored VAQTA, lot # N005796 with expiration date: 26-MAY-2018 (dose and route of administration were not reported). Temperature ranged to 1.6 degrees Celsius for the time frame of 8 hours and 30 minutes. There was previous temperature excursion with temperature of 1.3 degrees Celsius for 8 hours and 20 minutes. Digital data logger was not used. No adverse effects were reported. Product quality complaint was not involved. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1709USA003124.
11:15 Patient fell out of chair and hit his head on the gym floor, he lost conscientiousness, after he work up, he stated " I have a headache." Blood pressure elevated, sweating, kicking, confused initially but quickly able provide his name, birthdate, and current location. B/P 147/85 HR: 100  Oxygen Sat: 100% 11:20 am B/P 153/78 HR: 99 Oxygen Sat: 99% 11:40 Patient states " I'm not feeling alright but I think I'm going", patient was talking on the phone to his dad, unable to complete his sentence and began to fall out of his chair, patient  eye's began to twitch, legs kicking, but patient was able to state his name.  Patient was sent to the Emergency Room via ambulance. Father of the child will meet them at the hospital for further evaluation.
Chills Fever Aches Cough - took cold meds and bed rest for about 10 days.  - turned into server bronchitis for about 5 weeks      - treated with antibiotics, cough medicine, steriods
Severe abdominal pain, nauseous, diarrhea, vomiting, headache, joint pain, muscular aches.
Patient reported erythema and warmth at injection site one day receiving zoster vaccine. Was seen a few days later by MD to evaluate rash that was spreading. MD noted injection site erythema and warmth and suggested cool compresses on the area. Patient denied difficulty breathing, swallowing/chest pain, dizziness, change in vision, confusion, nausea/vomiting/diarrhea, and headache.
After receiving the vaccine I only had a slight sore arm and mild symptoms for a couple of days. When I got covid I had a sore throat, nasal congestion, and body aches. I called my doctor and I was prescribed Paxlovid. My covid symptoms lasted for about 3 days.
Patient began experiencing numbness to R ear and jaw at approx 3:15pm. She received the vaccine at approx 1 PM. Denies SOB. Not facial drooping. No hives
No adverse effects were reported; Patients were administered improperly stored vaccines doses; This spontaneous report was received from a registered nurse, concerning a patient of unspecified age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On 13-APR-2019, the patient was vaccinated with improperly storage doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis, lot #R034700 and expiration date 16-JUN-2020 (strength, dose, frequency and route of administration were not reported); with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis, lot #R033080 and expiration date 06-JUN-2020 (strength, dose, frequency and route of administration were not reported); and with hepatitis a vaccine, inactivated (VAQTA) for prophylaxis lot #S001485, expiration date 12-MAY-2020 and lot #R012988 and expiration date 30-MAY-2019. No adverse effects were reported.   The temperature excursion was reported as below 36°F (35.4°F) during a time frame of 27 minutes. Previous temperature excursion was reported as below 36°F (35.4°F) during a time frame of 15 minutes.   A digital data logger was involved.    This is one of several reports received from the same  reporter.; Sender's Comments:  US-009507513-1904USA012221: US-009507513-1905USA002744: US-009507513-1905USA002745: US-009507513-1905USA002746: US-009507513-1905USA002747: US-009507513-1905USA002748: US-009507513-1905USA002749: US-009507513-1905USA002750: US-009507513-1905USA002751: US-009507513-1905USA002752: US-009507513-1905USA002753: US-009507513-1905USA002754: US-009507513-1905USA002755: US-009507513-1905USA002757: US-009507513-1905USA002758: US-009507513-1905USA002759: US-009507513-1905USA002760: US-009507513-1905USA002761: US-009507513-1905USA002762: US-009507513-1905USA002763: US-009507513-1905USA002764: US-009507513-1905USA002765: US-009507513-1905USA002766: US-009507513-1905USA002767: US-009507513-1905USA002768: US-009507513-1905USA002769: US-009507513-1905USA002770:
The next morning after the vaccine I woke up feeling very run down, bone and body aches. No temp but I felt as if I did which resolved about that Friday. The fatigue and arm soreness lasted into that Sat evening and by that Sat evening all symptoms had subsided. 12/7 I started having a lot of sinus drainage, sneezing, watery eyes and fatigue with the symptoms getting worse by Thursday so I went and got a COVID-19 test at the local HCF (PRIVACY) and is currently awaiting the results.
After initial vaccine the arm was sore on Saturday, January 16th.  Upon waking up Sunday morning January 17th her arm arm felt like a tooth ache, throbbing. As the day went on her arm began to tingle and then her fingers and hand (left) went numb.  She called her PC who suggested she reach out to the vaccine provider and report to them her reaction.  Today, January 18th it is better but the tingling and numbness comes and goes.  It seems to get worse when using arm. She did report that she has high blood pressure, was on medication but no longer taking.
Information has been received from a nurse practitioner concerning an 18 year old female with Kleine-Levin syndrome who on 19-OCT-2007 was vaccinated with the first dose of Gardasil (lot # 658560/1062U).  Concomitant therapy included ORTHO TRI-CYCLEN LO.  On approximately 19-OCT-2007 the patient experienced vomiting, memory loss and extreme fatigue "almost to the point of paralysis."  Approximately a week later, the patient recovered from vomiting, memory loss and extreme fatigue.  Additional information has been requested.
Tired, exhaustion, Dizziness, headache, body aches, lack of appetite, nausea. Symptoms began immediately after 2nd vaccine.
Information has been received from a registered nurse concerning an 8 year old patient who was vaccinated with a dose of VARIVAX (Merck) (dose unspecified) and had a chickenpox breakthrough.  At the time of report, it was unknown if the patient recovered or not.
Arm was swollen and itchy. Reaction was not reported to the pharmacy until 10/24/2017 at which time the swelling and itching had started to subside.
Resident reports that she is not feeling well this morning. Reports cold chills, nausea. Stated that she vomited around 4am.
Suspect nurse gave double dose of Pfizer vaccine. Nurse reported only getting 3 doses from vial, suspect vial was not fully diluted.
Pt. states she had a reaction to the flu vaccine.  States she developed "swollen lymph nodes" under left arm pit; rcvd flu vaccine on left arm.  States saw Dr. early today & Dr. informed pt that swollen lymph nodes were related to yesterday's flu vaccine.  Per pt. Doc. ordered Motrin/ Adult for pain, heat & ice pack for treatment.   11/02/09 and 11/03/09  Medical records received for DOS 10/28/09. Final DX: Adverse reaction to influenza vaccine.  20 week gestation patient developed feeling of throat swelling 1hr s/p vaccine.  Benadryl and observation x1hr. Pos fetal heart tones. No change in sx.  Discharged.
This spontaneous report has been received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history, drug allergies, concurrent conditions and concomitant therapies were not reported. On 23-JAN-2018, the patient was vaccinated with an improperly stored VARIVAX with lot number N023959 and expiration date on 01-SEP-2019 (dose, dose number, route of administration and anatomical location were not provided), administered for prophylaxis, reconstituted using the sterile diluent (MERCK). It was reported that on an unspecified date, the vaccine was exposed to a temperature between -9 Centigrade degrees and 8 Centigrade degrees for 5 hours and 45 minutes. It was unknown if there was previous temperature excursion. No adverse effects were reported.
PATIENT HAD TRANSIENT VISION LOSS , DIZZINESS, VOMITING AND PERFUSE SWEATING.
This case was reported by a other health professional via call center representative and described the occurrence of hepatitis b virus test positive in a patient who received Hepatitis B vaccine. On an unknown date, the patient received Hepatitis B vaccine at an unknown dose. On an unknown date, several weeks after receiving Hepatitis B vaccine, the patient experienced hepatitis b virus test positive. On an unknown date, the outcome of the hepatitis b virus test positive was unknown. It was unknown if the reporter considered the hepatitis b virus test positive to be related to Hepatitis B vaccine. Additional details were received as follows: On an unknown date, 2 patients had received a dose of Hepatitis B vaccine. The number doses the patient received were unknown. After few weeks the patient underwent the hepatitis B vaccine test which was revealed to be positive. The reporter did not know the name of the test. Refer case US2015GSK126722, for the details of another patient vaccinated with Hepatitis B vaccine.
The vaccine, Flublock Quadrivalent, was stored outside of the expected temperature range (36-46F) for 96 hours with a maximum temperature reaching 51.8F. The manufacturer, has reported that the product becomes invalid when stored in temperatures above 46F up to 72 hours or more. CDC recommendations are to have the employee re-vaccinate and may do so immediately, no need to wait. Employee notified of event. Unable to reschedule at this time, as our clinic is out of stock. To notify employee when restocked.
Pt developed Red rash on neck and blister in mouth about 6 days after vaccine administration recieved JJ vaccine 08 APR 2021.  reports pressure/pain to bottom of both feet and pain to back of both calves R worse than left.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a 0.5 ml dose of GARDASIL (Lot # not reported).  Dose of the series was unknown.  It was reported that the patient fainted after receiving GARDASIL.  The patient sought unspecified medical attention.  Additional information has been requested.
Soreness at injection site 4 x 6cm erythema, fever, headache, nausea.
Development of Guillen-Barre Syndrome several weeks after injection. Loss of legs, loss of hearing, and loss of arms and hands.
Patient stated that after the second vaccine patient got eczema.; This spontaneous case was reported by a patient and describes the occurrence of ECZEMA (Patient stated that after the second vaccine patient got eczema.) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ECZEMA (Patient stated that after the second vaccine patient got eczema.). At the time of the report, ECZEMA (Patient stated that after the second vaccine patient got eczema.) was resolving.            Patient reported that along with the initial doses patient had also taken 1 booster dose last year, but got eczema after the second dose which at the moment is calming down.Thus the patient is now reluctant to take the 2 booster dose.  Concomitant drugs were not reported.  Treatment details were not given.
Pt recvd 1st dose of Engerix-B on 24APR91; Approx 1 wk p/vax pt exp dizziness, flushing, h/a (which came & went), ankle edema, & weight gain which occurred over the past 2-3 wks; Sx resolved by sitting down;
received /1st dose / in May 2019; received /1st dose / in May 2019 /2nd dose on 11Aug2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a male patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (received 1st dose in May 2019).   On 11th August 2021, the patient received the 2nd dose of Engerix B. On an unknown date, the patient received the 3rd dose of Engerix B. On 11th August 2021, unknown after receiving Engerix B and not applicable after receiving Engerix B, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the drug dose administration interval too long and incomplete course of vaccination were unknown.  Additional details provided were as follows: The age at vaccination was not reported for 2nd dose and it was not applicable for 3rd dose of Engerix B. The patient received 2nd dose of Engerix B on 11th August 2021, which led to lengthening of vaccination schedule. Till the time of reporting, the patient did not receive 3rd dose of Engerix B, which led to incomplete course of vaccination. The pharmacist did not have the patient's initials, date of birth, batch number and expiry date at the time of report. The reporter consented to follow-up.
I woke up with runny nose and constant sneezing, muscle aches and pains. Fever 103 and chills and uncontrollable vomiting. Suspects cerebral edema because of head ache and vomiting. Took 8 mg of dexmetholzone and Zofran. Neither were helpful. I took a shot of emetrex in case of a migraine.  Vomiting has stopped but fatigue and weakness persists.